Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Masters

Showing results (271-280 of 278) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 278 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2024
Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Elife|March 16, 2021
Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitryGregory G Grecco, Briana E Mork, Jui-Yen Huang, et al.
Transplantation|February 24, 2001
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantationH J Eisen, R E Hobbs, S F Davis, et al.
Cell Metabolism|April 11, 2020
Pimozide Alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting Skeletal Muscle Ketone OxidationRami Al Batran, Keshav Gopal, Megan E Capozzi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's diseaseCynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Plos One|February 8, 2011
Expanding the diversity of mycobacteriophages: insights into genome architecture and evolutionWelkin H Pope, Deborah Jacobs-Sera, Daniel A Russell, et al.
Pageof 28

Showing results (271-280 of 278) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 278 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2024
Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Elife|March 16, 2021
Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitryGregory G Grecco, Briana E Mork, Jui-Yen Huang, et al.
Transplantation|February 24, 2001
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantationH J Eisen, R E Hobbs, S F Davis, et al.
Cell Metabolism|April 11, 2020
Pimozide Alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting Skeletal Muscle Ketone OxidationRami Al Batran, Keshav Gopal, Megan E Capozzi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's diseaseCynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Plos One|February 8, 2011
Expanding the diversity of mycobacteriophages: insights into genome architecture and evolutionWelkin H Pope, Deborah Jacobs-Sera, Daniel A Russell, et al.
Pageof 28